Integrating diabetes technologies with team-based primary care for type 2 diabetes: A pilot trial

  • Matthew J. O’Brien
    Correspondence
    Corresponding author at: Northwestern University Division of General Internal Medicine and Geriatrics, 750 N. Lake Shore Drive, 6th Floor, Chicago, IL 60611, United States.
    Affiliations
    Northwestern University Feinberg School of Medicine, Chicago, IL, United States

    Institute of Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States

    Division of General Internal Medicine and Geriatrics, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States

    Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States
    Search for articles by this author
  • John J. Stephen
    Affiliations
    Northwestern University Feinberg School of Medicine, Chicago, IL, United States

    Division of General Internal Medicine and Geriatrics, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States
    Search for articles by this author
  • Kristine L. Norton
    Affiliations
    OptumLabs, Minnetonka, MN, United States
    Search for articles by this author
  • Thomas P. Meehan
    Affiliations
    ProHealth Physicians Inc., Farmington, CT, United States
    Search for articles by this author
  • Deneen Vojta
    Affiliations
    OptumLabs, Minnetonka, MN, United States
    Search for articles by this author
  • Ronald T. Ackermann
    Affiliations
    Northwestern University Feinberg School of Medicine, Chicago, IL, United States

    Institute of Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States

    Division of General Internal Medicine and Geriatrics, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States
    Search for articles by this author

      Highlights

      • Few studies have integrated diabetes technologies into primary care for diabetes.
      • We studied proactive care between office visits leveraging diabetes technologies
      • Reductions in weight and glucose were clinically and statistically significant.

      Summary

      This pilot trial studied a novel intervention that integrated diabetes technologies into team-based primary care for type 2 diabetes. We found clinically significant reductions in blood pressure, weight, and glucose. The latter two were statistically significant.

      Keywords

      To read this article in full you will need to make a payment
      Subscribe to Primary Care Diabetes
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Okemah J.
        • Peng J.
        • Quiñones M.
        Addressing clinical inertia in type 2 diabetes mellitus: a review.
        Adv. Ther. 2018; 35 (PMC6223992): 1735-1745
        • Khunti K.
        • Wolden M.L.
        • Thorsted B.L.
        • Andersen M.
        • Davies M.J.
        Clinical inertia in people with type 2 diabetes A retrospective cohort study of more than 80,000 people.
        Diabetes Care. 2013; 36: 3411-3417
        • Hou C.
        • Carter B.
        • Hewitt J.
        • Francisa T.
        • Mayor S.
        Do mobile phone applications improve glycemic control (HbA1c) in the self-management of diabetes? A systematic review, meta-analysis, and GRADE of 14 randomized trials.
        Diabetes Care. 2016; 39: 2089-2095
        • Chamberlain J.J.
        • Doyle-Delgado K.
        • Peterson L.
        • Skolnik N.
        Diabetes technology: review of the 2019 American Diabetes Association Standards of Medical Care in Diabetes.
        Ann. Intern. Med. 2019; 171: 415-420
        • Parati G.
        • Stergiou G.S.
        • Dolan E.
        • Bilo G.
        Blood pressure variability: clinical relevance and application.
        J. Clin. Hypertens. 2018; 20: 1133-1137
        • Poggiogalle E.
        • Jamshed H.
        • Peterson C.M.
        Circadian regulation of glucose, lipid, and energy metabolism in humans.
        Metabolism. 2018; 84 (PMC5995632): 11-27
        • Chan L.S.
        Minimal clinically important difference (MCID)—adding meaning to statistical inference.
        Am. J. Public Health. 2013; 103 (PMCID: PMC3828724): e24-25
        • American Diabetes Association
        Standards of medical care in diabetes—2020.
        Diabetes Care. 2020; 43
        • Law M.R.
        • Morris J.K.
        • Wald N.J.
        Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.
        BMJ. 2009; 338 (PMCID: PMC2684577): b1665
        • Jensen M.D.
        • Ryan D.H.
        • Apovian C.M.
        • et al.
        2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society.
        J. Am. Coll. Cardiol. 2014; 63: 2985-3023
        • Wagner E.H.
        • Flinter M.
        • Hsu C.
        • et al.
        Effective team-based primary care: observations from innovative practices.
        BMC Fam. Pract. 2017; 18 (PMC5289007): 13
        • Gandrud L.
        • Altan A.
        • Buzinec P.
        • et al.
        Intensive remote monitoring versus conventional care in type 1 diabetes: a randomized controlled trial.
        Pediatr. Diabetes. 2018; 19: 1086-1093
        • Klonoff D.C.
        • Parkes J.L.
        • Kovatchev B.P.
        • et al.
        Investigation of the accuracy of 18 marketed blood glucose monitors.
        Diabetes Care. 2018; 41: 1681-1688
        • Yoo H.J.
        • Park M.S.
        • Kim T.N.
        • et al.
        A Ubiquitous Chronic Disease Care system using cellular phones and the internet.
        Diabet. Med. 2009; 26: 628-635
        • Nicolucci A.
        • Cercone S.
        • Chiriatti A.
        • Muscas F.
        • Gensini G.
        A randomized trial on home telemonitoring for the management of metabolic and cardiovascular risk in patients with type 2 diabetes.
        Diabetes Technol. Ther. 2015; 17: 563-570
        • Wild S.H.
        • Hanley J.
        • Lewis S.C.
        • et al.
        Supported telemonitoring and glycemic control in people with type 2 diabetes: the telescot diabetes pragmatic multicenter randomized controlled trial.
        PLoS Med. 2016; 13 (PMC4961438)e1002098
        • Lee J.Y.
        • Chan C.K.Y.
        • Chua S.S.
        • et al.
        Telemonitoring and team-based management of glycemic control on people with type 2 diabetes: a cluster-randomized controlled trial.
        J. Gen. Intern. Med. 2020; 35 (PMC6957608): 87-94